A Phase I Study of Triapine [OCX 0191] in Combination With High Dose Ara-C (Hi-DAC) in Patients With Advanced Hematologic Malignancies
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2013
At a glance
- Drugs OCX 191 (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 15 Jul 2008 Completion date identified as Jul 2008, as reported by ClinicalTrials.gov.
- 15 Jul 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 09 Sep 2005 New trial record.